The global small-molecule tyrosine kinase inhibitor market is expected to grow at a significant CAGR of 7.3% during the forecast period. TKIs (tyrosine kinase inhibitors) are small molecules that block intracellular signalling pathways in tumour cells, causing deregulation of key cell functions such as proliferation and differentiation. Furthermore, small-molecule inhibitors (SMIs) are among the most effective drugs for targeted cancer therapy, according to the National Center for Biotechnology Information (NCBI). As a result, the rising prevalence of cancer is increasing demand for small molecule tyrosine kinase inhibitors, which is propelling the global small molecule tyrosine kinase inhibitor market forward.
Furthermore, there were 18.1 million new cancer cases and 9.5 million cancer-related mortalities across the globe in 2020, with the number of cancer-related mortalities expected to rise to 29.5 million and 16.4 million by 2040. To stay competitive, market players are adopting various strategies such as mergers and acquisitions, geographical expansion, partnerships and collaborations, and new product launches, which contribute significantly to market growth.
To Request a Sample of our Report on Small Molecule Tyrosine Kinase Inhibitor Market: https://www.omrglobal.com/request-sample/small-molecule-tyrosine-kinase-inhibitor-market
Market Coverage
- The market number available for – 2023-2030
- Base year- 2022
- Forecast period- 2024-2030
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape-Merck Group, Novartis AG, Pfizer Inc., Sanofi SA, GlaxoSmithKline plc.
Small Molecule Tyrosine Kinase Inhibitor Market Segmentation
By Type
- Phase1
- Phase1/2
- Phase2
- Phase2/3
- Phase3
By Application
- Lung cancer
- Breast cancer
- Others
A full Report of Small Molecule Tyrosine Kinase Inhibitor Market is Available @ https://www.omrglobal.com/industry-reports/small-molecule-tyrosine-kinase-inhibitor-market
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Merck Group
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- GlaxoSmithKline PLC
- Biogen Idec
- Bayer Healthcare Pharmaceuticals
- Johnson & Johnson, Inc.
- Tolero Pharmaceutical
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/small-molecule-tyrosine-kinase-inhibitor-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404